CS01Source stored · extraction verifiedFiled 21 Mar 2026 · 10 pages
Confirmation statement made up to 8 March 2026
The dated registered-holder statement used for the two founders' visible ordinary-share numerator.
Active at the evidence cutoffUnited KingdomVerified registry identity
Company evidence record
CUSP AI LIMITED
The reviewed Companies House documents identify CUSP AI LIMITED as UK company 15549537. A confirmation statement attributes 9,208,472 ordinary shares to founders Alyn Chad Edwards and Max Welling; dividing that dated numerator by the 28,239,626 issued shares reported after an allotment ten days later gives a 32.61% pre-Series-B reference. The mismatch in evidence dates means this is not a synchronized or fully diluted cap table, and the reviewed record does not disclose the later $450 million Series B allocation, Sovereign AI's ticket, founder dilution, secondary sales or current voting control.
32.61%
Founder reference position
dated pre-Series-B issued-share basis
10 days
Evidence-date gap
founder numerator versus share denominator
Evidence library
Documents behind the record
SH01Source stored · extraction verifiedFiled 16 Apr 2026 · 6 pages
Return of allotment for shares issued on 18 March 2026
The allotment filing that supplies the later pre-Series-B issued-share denominator and the priced Series A3 issue.
ACCOUNTSSource stored · extraction verifiedFiled 4 Dec 2025 · 14 pages
Accounts for the period ended 31 March 2025
The company's first filed accounts, used only for the dated cash, net-assets, accumulated-loss and average-employee snapshot.
Evidence boundary
What the filings establish, and what remains unresolved
Every finding stays tied to the reviewed documents. Transaction terms and ownership conclusions outside that record remain explicit limits.
Established by the record
- 01
The reviewed filings identify CUSP AI LIMITED as UK company number 15549537 and place the company in Cambridge, consistent with the legal identity preserved in the article package.
- 02
The confirmation statement attributes 4,208,472 ordinary shares to Alyn Chad Edwards and 5,000,000 ordinary shares to Max Welling at its 8 March 2026 reference date.
- 03
The 18 March allotment reports 28,239,626 issued shares after issuing 2,510,222 Series A3 shares at £18.19 each.
- 04
The first filed accounts report approximately £22.03 million of cash, £23.29 million of net assets, a £1.11 million accumulated loss and 12 average employees at 31 March 2025.
Not established by the record
- 01
The founder holdings and issued-share denominator are ten days apart, so 32.61% is a dated reference rather than a synchronized or fully diluted cap table.
- 02
An SH01 reports issued shares, class and consideration; it does not identify every recipient or establish the ownership, voting rights or fully diluted economics of the later Series B.
- 03
The reviewed filings do not disclose Sovereign AI's ticket, investor-by-investor Series B allocations, secondary sales, founder dilution or current voting control.
- 04
The March 2025 accounts predate the March 2026 allotment and July 2026 Series B, so they are not evidence of current cash, runway, workforce or net assets.
Related analysis
CuspAI's Founders Held 32.61% Before The $450m Series B
CuspAI's founders held 32.61% before its $450m Series B, while UK sovereign capital entered a company whose post-round ownership is not yet public.
Read the analysis